On 1st March 2023, the Financial Times Group (FT Group) acquired the product and consulting assets of Wavteq Group Limited (Wavteq). The Wavteq brands; including Amplify, IncentivesFlow, InvestmentFlow, InvestmentMap, Influencers, Institute and their strategy and advisory services have joined the fDi Intelligence portfolio.
FT has not acquired the lead generation division of Wavteq, which can still be found here.
For further information visit; newproducts.fdiintelligence.com or read press release.
The pharmaceutical industry has witnessed considerable growth in recent years. IQVIA estimated the global market size of the industry at USD 1.27 trillion by the end of 2020. This growth is noteworthy as compared to the 2001 market size of USD 390 billion. Because many major pharma companies have their roots in the US, the country has come to the forefront of the national market for pharmaceuticals globally, followed by emerging countries including Brazil, India, Russia, Colombia and Egypt, to name a few. Latin America accounts for the least share of the global pharma market size despite growing revenues across the globe. The pharma revenue projections show that the North American and the European markets will be the pioneers in 2024, although the yearly growth rates of the emerging pharma markets have been robust in recent years.
Keeping in mind this understanding, Wavteq Institute has curated our latest industry blueprint on the Pharmaceutical sector that captures a holistic view of the trends in 2021 & beyond, with a focus on the influencing factors, key trends, greenfield investments, M&A activity, key stakeholders and category insights.
The report is available exclusively for the subscribers of Wavteq Institute, a continuous learning & market intelligence platform by Wavteq for the economic development community.
To know more about this briefing or to explore Wavteq Institute, get in touch for a live demo of all the platform has to offer!